Recent Advances in AIDS and HIV Research

艾滋病和艾滋病毒研究的最新进展

基本信息

项目摘要

Description (as provided by the applicant): Since 1998, the NIH-funded Centers for AIDS Research (CFAR) have hosted an annual one day National CFAR Scientific Symposium in conjunction with the annual CFAR Directors'/Administrators' meeting. The purpose of the CFAR scientific symposium is to present, in a public forum, recent "cutting edge" advances in HIV/AIDS research for an average attendance of approximately 250-300. The intimate size of the meeting promotes opportunities for interactions between young and more senior investigators that would not be available at the larger annual scientific meetings related to HIV/AIDS. The meeting location rotates so that it is hosted each year by a different CFAR site. This provides geographic diversity for the venue and opportunities for a broader array of participants than for similar research symposia. As has been done for the past fifteen years, one of several AIDS-related research areas is the focus of the annual symposium. In 2011, the Duke University CFAR hosted the 15th Annual CFAR Research Symposium with focus on five scientific areas: "Host-Viral Interactions during HIV Infection", "HIV-Associated Malignancies and Co-Infections", "Emerging Vaccine Strategies", "HIV/AIDS Health Disparities", and "Approaches to an HIV Cure". Speakers were selected from the various NIH-funded Centers for AIDS Research leadership, their scientific membership, and from nationally and internationally recognized research institutions. In addition to the participating CFAR Directors and invited leaders in the field, the remaining participants for the annual National CFAR Symposia are chosen based on specific criteria. First preference is given to young investigators who have received developmental funds from an NIH-funded CFAR program; second preference to young investigators with demonstrable potential in HIV/AIDS research; third preference is to other senior investigators engaged in HIV/AIDS research. In all cases women and individuals from underrepresented ethnic groups are encouraged to attend through targeted advertising and travel scholarships. Continuing Medical Education credits have been offered for attendees and access to web casts of the symposia are now available for interested investigators who are not able to attend.
描述(由申请人提供):自1998年以来,美国国立卫生研究院资助的艾滋病研究中心(CFAR)在召开年度CFAR主任/管理者会议的同时,每年举办一次为期一天的全国CFAR科学研讨会。CFAR科学研讨会的目的是在一个公共论坛上介绍艾滋病毒/艾滋病研究的最新“前沿”进展,平均出席人数约为250-300人。会议的规模之大,促进了青年和较资深研究人员之间的互动机会,这是与艾滋病毒/艾滋病有关的较大年度科学会议所不具备的。会议地点轮换,每年由不同的CFAR地点主办。与类似的研究研讨会相比,这为会场提供了地理多样性,并为更多的参与者提供了机会。正如过去15年所做的那样,与艾滋病有关的几个研究领域之一是年度研讨会的焦点。2011年,杜克大学CFAR主办了第15届CFAR年度研究研讨会,重点讨论了五个科学领域:“艾滋病毒感染期间的宿主-病毒相互作用”、“艾滋病毒相关恶性肿瘤和共同感染”、“新疫苗战略”、“艾滋病毒/艾滋病健康差距”和“艾滋病毒治疗方法”。演讲者是从国家卫生研究院资助的各个艾滋病研究领导中心、其科学成员以及国家和国际公认的研究机构中挑选出来的。除了参加的CFAR主任和该领域的特邀领导人外,每年的CFAR年度全国CFAR研讨会的其余参与者是根据特定标准挑选的。第一优先选择从NIH资助的CFAR项目获得发展资金的年轻调查人员;第二优先选择在艾滋病毒/艾滋病研究方面具有明显潜力的年轻调查人员;第三优先选择从事艾滋病毒/艾滋病研究的其他高级调查人员。在所有情况下,都通过有针对性的广告和旅行奖学金鼓励妇女和代表人数不足的族裔群体的个人参加。为与会者提供了继续医学教育学分,不能参加的感兴趣的调查人员现在可以访问研讨会的网络广播。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PAUL A VOLBERDING其他文献

PAUL A VOLBERDING的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PAUL A VOLBERDING', 18)}}的其他基金

Administrative Core
行政核心
  • 批准号:
    8699357
  • 财政年份:
    2013
  • 资助金额:
    $ 1.5万
  • 项目类别:
Recent Advances in AIDS and HIV Research
艾滋病和艾滋病毒研究的最新进展
  • 批准号:
    8705971
  • 财政年份:
    2012
  • 资助金额:
    $ 1.5万
  • 项目类别:
Recent Advances in AIDS and HIV Research
艾滋病和艾滋病毒研究的最新进展
  • 批准号:
    8406106
  • 财政年份:
    2012
  • 资助金额:
    $ 1.5万
  • 项目类别:
Recent Advances in AIDS and HIV Research
艾滋病和艾滋病毒研究的最新进展
  • 批准号:
    8719012
  • 财政年份:
    2012
  • 资助金额:
    $ 1.5万
  • 项目类别:
Recent Advances in AIDS and HIV Research
艾滋病和艾滋病毒研究的最新进展
  • 批准号:
    8895256
  • 财政年份:
    2012
  • 资助金额:
    $ 1.5万
  • 项目类别:
UCSF-GIVI Center for AIDS Research: EARLI Study Arm B Supplement
UCSF-GIVI 艾滋病研究中心:EARLI 研究组 B 补充材料
  • 批准号:
    8335653
  • 财政年份:
    2011
  • 资助金额:
    $ 1.5万
  • 项目类别:
UCSF-GIVI Center for AIDS Research
加州大学旧金山分校-GIVI 艾滋病研究中心
  • 批准号:
    8129862
  • 财政年份:
    2010
  • 资助金额:
    $ 1.5万
  • 项目类别:
UCSF-GIVI Center for AIDS Research
加州大学旧金山分校-GIVI 艾滋病研究中心
  • 批准号:
    8129870
  • 财政年份:
    2010
  • 资助金额:
    $ 1.5万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    7694827
  • 财政年份:
    2008
  • 资助金额:
    $ 1.5万
  • 项目类别:
Developmental Core
发展核心
  • 批准号:
    7681521
  • 财政年份:
    2008
  • 资助金额:
    $ 1.5万
  • 项目类别:

相似海外基金

RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    10219039
  • 财政年份:
    2020
  • 资助金额:
    $ 1.5万
  • 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9981476
  • 财政年份:
    2019
  • 资助金额:
    $ 1.5万
  • 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9364184
  • 财政年份:
    2016
  • 资助金额:
    $ 1.5万
  • 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
  • 批准号:
    236932
  • 财政年份:
    2011
  • 资助金额:
    $ 1.5万
  • 项目类别:
    Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554155
  • 财政年份:
    1991
  • 资助金额:
    $ 1.5万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6766860
  • 财政年份:
    1991
  • 资助金额:
    $ 1.5万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554156
  • 财政年份:
    1991
  • 资助金额:
    $ 1.5万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6256640
  • 财政年份:
    1991
  • 资助金额:
    $ 1.5万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
  • 批准号:
    2063342
  • 财政年份:
    1991
  • 资助金额:
    $ 1.5万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6091256
  • 财政年份:
    1991
  • 资助金额:
    $ 1.5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了